Increased tumor uptake of 3-(123)I-Iodo-L-alpha-methyltyrosine after preloading with amino acids: an in vivo animal imaging study.
暂无分享,去创建一个
[1] M. Schwaiger,et al. Correlation Between Postoperative 3-[123I]Iodo-l-α-Methyltyrosine Uptake and Survival in Patients with Gliomas , 2001 .
[2] C. Vanhove,et al. Diagnosis of recurrent head and neck squamous cell carcinoma with 3-[123I]iodo-L-α-methyltyrosine SPET , 2001, European Journal of Nuclear Medicine.
[3] W Vaalburg,et al. Radiolabeled amino acids: basic aspects and clinical applications in oncology. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] A. Bossuyt,et al. In vitro characterization of the influx of 3-[125I]iodo-L-alpha-methyltyrosine and 2-[125I]iodo-L-tyrosine into U266 human myeloma cells: evidence for system T transport. , 2001, Nuclear medicine and biology.
[5] E. de Vries,et al. Uptake mechanisms of L-3-[125I]iodo-alpha-methyl-tyrosine in a human small-cell lung cancer cell line: comparison with L-1-[14C]tyrosine , 2001, Nuclear medicine communications.
[6] K. Langen,et al. 3-[123I]iodo-alpha-methyl-L-tyrosine transport and 4F2 antigen expression in human glioma cells. , 2001, Nuclear medicine and biology.
[7] M. Schwaiger,et al. Correlation between postoperative 3-[(123)I]iodo-L-alpha-methyltyrosine uptake and survival in patients with gliomas. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[8] N. Thompson,et al. TA1/LAT-1/CD98 Light Chain and System L Activity, but Not 4F2/CD98 Heavy Chain, Respond to Arginine Availability in Rat Hepatic Cells , 2000, The Journal of Biological Chemistry.
[9] I. Paulsen,et al. New Glycoprotein-Associated Amino Acid Transporters , 1999, The Journal of Membrane Biology.
[10] M. Schwaiger,et al. Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivo. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[11] L. Kühn,et al. Amino acid transport of y+L‐type by heterodimers of 4F2hc/CD98 and members of the glycoprotein‐associated amino acid transporter family , 1999, The EMBO journal.
[12] H. Groen,et al. Feasibility of tumor imaging using L-3-[iodine-123]-iodo-alpha-methyl-tyrosine in extracranial tumors. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[13] H. Biersack,et al. Simple preparation of l-3-Iodo-α-methyl tyrosine suitable for use in kit preparations , 1995 .
[14] Peters Am,et al. Graphical analysis of dynamic data: the Patlak-Rutland plot. , 1994 .
[15] A. Peters. Graphical analysis of dynamic data: the Patlak-Rutland plot. , 1994, Nuclear medicine communications.
[16] H. Herzog,et al. Brain and brain tumor uptake of L-3-[123I]iodo-alpha-methyl tyrosine: competition with natural L-amino acids. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[17] H. Coenen,et al. Cerebral metabolism of L-[2-18F]fluorotyrosine, a new PET tracer of protein synthesis. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[18] H. Christensen,et al. Organic ion transport during seven decades. The amino acids. , 1984, Biochimica et biophysica acta.
[19] H. Christensen,et al. Intensified gradients for endogenous amino acid substrates for transport system L on injecting a specific competitor for that system. , 1981, Life sciences.
[20] D A Goldstein,et al. The flow of solute and solvent across a two-membrane system. , 1963, Journal of theoretical biology.